These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6146587)

  • 1. A census of out-patients attending for 'depot' medication at a Glasgow Psychiatric Hospital.
    Turner GN
    Health Bull (Edinb); 1984 May; 42(3):141-5. PubMed ID: 6146587
    [No Abstract]   [Full Text] [Related]  

  • 2. The attitude of patients towards antipsychotic depot treatment.
    Heres S; Schmitz FS; Leucht S; Pajonk FG
    Int Clin Psychopharmacol; 2007 Sep; 22(5):275-82. PubMed ID: 17690596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
    Gutwinski S; Müller P; Koller M
    Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot antipsychotics. Patient characteristics and prescribing pattern.
    Al-Sughayir MA
    Saudi Med J; 2000 Dec; 21(12):1178-81. PubMed ID: 11360095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.
    Marinis TD; Saleem PT; Glue P; Arnoldussen WJ; Teijeiro R; Lex A; Latif MA; Medori R
    Pharmacopsychiatry; 2007 Nov; 40(6):257-63. PubMed ID: 18030649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.
    Patel MX; De Zoysa N; Bernadt M; David A
    J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depot Neuroleptic preparations in psychiatric practice (author's transl)].
    Svestka J; Bártová D; Cesková E; Rysánek R
    Cesk Psychiatr; 1981 Jun; 77(3):187-97. PubMed ID: 6119161
    [No Abstract]   [Full Text] [Related]  

  • 11. The subjective experiences of people who regularly receive depot neuroleptic medication in the community.
    Phillips L; McCann E
    J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of depot neuroleptic medication in psychiatric inpatients.
    Citrome L; Levine J; Allingham B
    Psychopharmacol Bull; 1996; 32(3):321-6. PubMed ID: 8961774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic medication coprescribing in a large state hospital system.
    Jaffe AB; Levine J
    Pharmacoepidemiol Drug Saf; 2003; 12(1):41-8. PubMed ID: 12616846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
    Lai YC; Chiou CC; Chen CH; Huang MC
    J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
    [No Abstract]   [Full Text] [Related]  

  • 15. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

  • 16. Demographic predictors of the use of injectable versus oral antipsychotic medications in outpatients.
    Price N; Glazer W; Morgenstern H
    Am J Psychiatry; 1985 Dec; 142(12):1491-2. PubMed ID: 2866719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of teaching practice nurses to carry out structured assessments of patients receiving depot antipsychotic injections.
    Burns T; Millar E; Garland C; Kendrick T; Chisholm B; Ross F
    Br J Gen Pract; 1998 Dec; 48(437):1845-8. PubMed ID: 10198505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prescribing practice of psychotropic drugs in a psychiatric university clinic].
    Ambühl B; Würmle O; Michel K
    Psychiatr Prax; 1993 Mar; 20(2):70-3. PubMed ID: 8103601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum creatine kinase in patients treated with depot neuroleptics. A pilot study].
    Bjørndal F; Lauritsen B; Lyngbye J; Waarst S
    Ugeskr Laeger; 1979 Dec; 141(51):3514-6. PubMed ID: 44041
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.